class name | count |
---|---|
rosids | 14 |
asterids | 7 |
Liliopsida | 7 |
Spermatophyta | 5 |
eudicotyledons | 5 |
Magnoliophyta | 2 |
class name | count |
---|---|
Rosaceae
![]() |
5 |
Ericaceae
![]() |
3 |
Posidoniaceae
![]() |
3 |
Cupressaceae
![]() |
2 |
Phyllanthaceae
![]() |
2 |
Apiaceae
![]() |
2 |
Orchidaceae
![]() |
2 |
Asteraceae
![]() |
2 |
Pinaceae
![]() |
2 |
Anacardiaceae
![]() |
1 |
Schisandraceae
![]() |
1 |
Podocarpaceae
![]() |
1 |
Rutaceae
![]() |
1 |
Proteaceae
![]() |
1 |
Zingiberaceae
![]() |
1 |
Amaryllidaceae
![]() |
1 |
Caryophyllaceae
![]() |
1 |
Lauraceae
![]() |
1 |
Geraniaceae
![]() |
1 |
Salicaceae
![]() |
1 |
br08003 Category | # of metabolite |
---|---|
Gallotannins | 1 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Gallotannins | C01108 | C00002670 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00002644
![]() |
Catechol
/ Pyrocatechol |
CHEMBL280998
|
C034221
|
148 / 82 / 64 | 22 / 5 |
![]() |
C00002656
![]() |
Hydroquinone
/ 1,4-Benzenediol |
CHEMBL537
|
C031927
|
55 / 48 / 51 | 156 / 14 |
![]() |
C00002665
![]() |
Phloroglucinol
|
CHEMBL473159
|
D010696
|
3 / 4 / 2 | 8 / 2 |
![]() |
C00002670
![]() |
Pyrogallol
|
CHEMBL307145
|
D011748
|
115 / 69 / 60 | 8 / 2 |
![]() |
C00002671
![]() |
Resorcinol
|
CHEMBL24147
|
C031389
|
21 / 24 / 25 | 3 / 1 |
![]() |
C00031480
![]() |
1,2,4-Trihydroxybenzene
|
C013038
|
66 / 2 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P00918 | Carbonic anhydrase 2 | Lyase | C00002644 C00002656 C00002670 C00002671 | 1 / 2 |
P23280 | Carbonic anhydrase 6 | Lyase | C00002644 C00002656 C00002670 C00002671 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002644 C00002656 C00002670 C00002671 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00002644 C00002656 C00002670 C00002671 | 11 / 10 |
P10145 | Interleukin-8 | Secreted protein | C00002644 C00002656 C00002670 C00002671 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002644 C00002656 C00002670 C00002671 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002644 C00002656 C00002670 C00002671 | 3 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002644 C00002656 C00002670 C00002671 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002644 C00002656 C00002670 C00002671 | 0 / 1 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00002644 C00002656 C00002671 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002644 C00002656 C00002670 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002644 C00002656 C00002670 | 1 / 1 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00002644 C00002656 C00002671 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002644 C00002656 C00002670 | 2 / 2 |
P10275 | Androgen receptor | NR3C4 | C00002656 C00002670 C00002671 | 3 / 4 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002644 C00002656 C00002670 | 0 / 3 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00002644 C00002656 C00002671 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002644 C00002656 C00002671 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002644 C00002656 C00002671 | 0 / 1 |
P14679 | Tyrosinase | Oxidoreductase | C00002665 C00002670 C00002671 | 4 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002644 C00002656 C00002670 | 0 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | C00002644 C00002656 C00002671 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00002644 C00002656 C00002671 | 1 / 1 |
O75496 | Geminin | Unclassified protein | C00002644 C00002656 C00002671 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002644 C00002656 C00002671 | 1 / 2 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002644 C00002665 C00002670 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00002644 C00002656 C00002670 | 0 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00002644 C00002656 C00002671 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002644 C00002656 C00002670 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002644 C00002656 C00002670 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00002644 C00002670 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002644 C00002670 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00002644 C00002670 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00002644 C00002670 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002644 C00002670 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002644 C00002670 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002644 C00002670 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002644 C00002670 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002644 C00002670 | 1 / 1 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002644 C00002670 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00002644 C00002670 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002644 C00002670 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002644 C00002670 | 0 / 1 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00002644 C00002656 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00002644 C00002656 | 1 / 2 |
P40225 | Thrombopoietin | Unclassified protein | C00002644 C00002656 | 1 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002644 C00002670 | 1 / 8 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002644 C00002656 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00002644 C00002670 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002644 C00002670 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002644 C00002670 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00002644 C00002670 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002644 C00002670 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00002644 C00002670 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00002644 C00002656 | 1 / 1 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002644 C00002670 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002644 C00002670 | 1 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002644 C00002670 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002644 C00002670 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002644 C00002670 | 1 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00002644 C00002670 | 0 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002644 C00002656 | 2 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002644 C00002670 | 1 / 1 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002644 C00002670 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002644 C00002656 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002644 C00002670 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002644 C00002656 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002644 C00002656 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00002644 C00002670 | 2 / 2 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002644 C00002656 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00002644 C00002670 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002644 C00002670 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002644 C00002670 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00002644 C00002670 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00002644 C00002670 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00002644 C00002670 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00002644 C00002670 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002644 C00002670 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002644 C00002670 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00002644 C00002670 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002644 C00002670 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002644 C00002670 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002644 C00002670 | 1 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00002644 C00002670 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002644 C00002670 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00002644 C00002670 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002644 C00002670 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00002644 C00002670 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002644 C00002670 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002644 C00002670 | 1 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002644 C00002670 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002644 C00002656 | 0 / 0 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00002644 C00002656 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002644 C00002656 | 4 / 3 |
P17252 | Protein kinase C alpha type | Alpha | C00002644 C00002670 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002644 C00002670 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002644 C00002670 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00002644 C00002670 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002644 C00002670 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002644 C00002670 | 2 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002644 C00002670 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002644 C00002670 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002644 C00002670 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00002644 C00002670 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002644 C00002670 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002644 C00002670 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002644 C00002670 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00002644 C00002656 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002644 C00002670 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002644 C00002670 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002644 C00002670 | 2 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002644 C00002670 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002644 C00002670 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002644 C00002670 | 2 / 2 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002644 C00002670 | 1 / 1 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002644 C00002670 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00002644 C00002656 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002644 C00002656 | 1 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00002644 C00002656 | 5 / 2 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002644 C00002670 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00002644 C00002670 | 2 / 1 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002644 C00002670 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00002644 C00002670 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002644 C00002670 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00002644 C00002670 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002644 C00002670 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002644 C00002670 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002644 C00002670 | 0 / 1 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002644 C00002670 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00002644 C00002670 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00002644 C00002670 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002644 C00002670 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002644 C00002670 | 1 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002656 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00002644 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00002670 | 1 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00002644 | 1 / 3 |
P22894 | Neutrophil collagenase | M10A | C00002644 | 0 / 0 |
P56817 | Beta-secretase 1 | A1A | C00002665 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002644 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00002644 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002644 | 5 / 3 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002670 | 5 / 1 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002644 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00002644 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00002644 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002644 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00002644 | 1 / 1 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002656 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002670 | 0 / 0 |
P68871 | Hemoglobin subunit beta | Secreted protein | C00002656 | 4 / 4 |
P16581 | E-selectin | Adhesion | C00002670 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002644 | 1 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00002656 | 3 / 1 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00002656 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00002644 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00002644 | 1 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002656 | 0 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00002656 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00002670 | 2 / 3 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002644 | 4 / 1 |
Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00002656 | 0 / 0 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00002644 | 1 / 1 |
P02768 | Serum albumin | Secreted protein | C00002670 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002644 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00002656 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002656 | 1 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002670 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002670 | 1 / 4 |
P14151 | L-selectin | Adhesion | C00002670 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002644
C00002656
C00002665
C00002670
|
6356 | CCL11, SCYA11 | chemokine (C-C motif) ligand 11 |
C00002644
C00002656
C00031480
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002644
C00002656
C00031480
|
3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00002644
C00002656
C00031480
|
7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00002644
C00002656
C00031480
|
2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00002644
C00002656
C00031480
|
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00002644
C00002656
C00031480
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00002644
C00002656
C00031480
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00002644
C00002656
C00031480
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00002644
C00002656
C00031480
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00002644
C00002656
C00031480
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00002644
C00002656
C00031480
|
3145 | HMBS, PBG-D, PBGD, PORC, UPS | hydroxymethylbilane synthase (EC:2.5.1.61) |
C00002644
C00002656
C00031480
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00002656
C00031480
|
847 | CAT | catalase (EC:1.11.1.6) |
C00002656
C00002670
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002656
C00002670
|
3337 | DNAJB1, HSPF1, Hdj1, Hsp40, RSPH16B, Sis1 | DnaJ (Hsp40) homolog, subfamily B, member 1 |
C00002656
C00031480
|
1436 | CSF1R, C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R | colony stimulating factor 1 receptor (EC:2.7.10.1) |
C00002656
C00031480
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00002656
C00002670
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00002644
C00002656
|
9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00002656
C00002665
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00002656
C00031480
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00002656
C00031480
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002644
C00002656
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00002656
C00031480
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002656
C00031480
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00002644
C00002656
|
4778 | NFE2, NF-E2, p45 | nuclear factor, erythroid 2 |
C00002656
C00031480
|
2993 | GYPA, CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI, HGpSta(C), MN, MNS, PAS-2 | glycophorin A (MNS blood group) |
C00002656
C00031480
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00002656
C00002665
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002656
C00002670
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00002656
C00031480
|
8337 | HIST2H2AA3, H2A, H2A.2, H2A/O, H2A/q, H2AFO, H2a-615, HIST2H2AA | histone cluster 2, H2aa3 |
C00002656
C00031480
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00002644
C00002670
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002656
C00002665
|
8614 | STC2, STC-2, STCRP | stanniocalcin 2 |
C00002656
|
3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
C00031480
|
3303 | HSPA1A, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1 | heat shock 70kDa protein 1A |
C00031480
|
3304 | HSPA1B, HSP70-1B, HSP70-2 | heat shock 70kDa protein 1B |
C00031480
|
3113 | HLA-DPA1, DP(W3), DP(W4), HLA-DP1A, HLADP, HLASB, PLT1 | major histocompatibility complex, class II, DP alpha 1 |
C00031480
|
8339 | HIST1H2BG, H2B.1A, H2B/a, H2BFA, dJ221C16.8 | histone cluster 1, H2bg |
C00031480
|
3280 | HES1, HES-1, HHL, HRY, bHLHb39 | hes family bHLH transcription factor 1 |
C00031480
|
3674 | ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
C00031480
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00031480
|
3720 | JARID2, JMJ | jumonji, AT rich interactive domain 2 |
C00031480
|
3750 | KCND1, KV4.1 | potassium voltage-gated channel, Shal-related subfamily, member 1 |
C00031480
|
9817 | KEAP1, INrf2, KLHL19 | kelch-like ECH-associated protein 1 |
C00031480
|
8440 | NCK2, GRB4, NCKbeta | NCK adaptor protein 2 |
C00031480
|
2812 | GP1BB, BDPLT1, BS, CD42C, GPIBB | glycoprotein Ib (platelet), beta polypeptide |
C00031480
|
22822 | PHLDA1, DT1P1B11, PHRIP, TDAG51 | pleckstrin homology-like domain, family A, member 1 |
C00031480
|
123 | PLIN2, ADFP, ADRP | perilipin 2 |
C00031480
|
4659 | PPP1R12A, M130, MBS, MYPT1 | protein phosphatase 1, regulatory subunit 12A |
C00031480
|
58497 | PRUNE, DRES-17, DRES17, HTCD37 | prune exopolyphosphatase (EC:3.6.1.1) |
C00031480
|
57403 | RAB22A | RAB22A, member RAS oncogene family |
C00031480
|
6138 | RPL15, EC45, L15, RPL10, RPLY10, RPYL10 | ribosomal protein L15 |
C00031480
|
6125 | RPL5, DBA6, L5 | ribosomal protein L5 |
C00031480
|
5176 | SERPINF1, EPC-1, OI12, OI6, PEDF | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
C00031480
|
6452 | SH3BP2, 3BP-2, 3BP2, CRBM, CRPM | SH3-domain binding protein 2 |
C00031480
|
6653 | SORL1, C11orf32, LR11, LRP9, SORLA, SorLA-1, gp250 | sortilin-related receptor, L(DLR class) A repeats containing |
C00031480
|
8683 | SRSF9, SFRS9, SRp30c | serine/arginine-rich splicing factor 9 |
C00031480
|
2781 | GNAZ | guanine nucleotide binding protein (G protein), alpha z polypeptide |
C00031480
|
25907 | TMEM158, BBP, RIS1, p40BBP | transmembrane protein 158 (gene/pseudogene) |
C00031480
|
26088 | GGA1 | golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
C00031480
|
126626 | GABPB2 | GA binding protein transcription factor, beta subunit 2 |
C00031480
|
9654 | TTLL4 | tubulin tyrosine ligase-like family, member 4 |
C00031480
|
2232 | FDXR, ADXR | ferredoxin reductase (EC:1.18.1.6) |
C00031480
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00002671
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002671
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00002671
|
64782 | AEN, ISG20L1, pp12744 | apoptosis enhancing nuclease |
C00002656
|
217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00002656
|
396 | ARHGDIA, GDIA1, NPHS8, RHOGDI, RHOGDI-1 | Rho GDP dissociation inhibitor (GDI) alpha |
C00002656
|
468 | ATF4, CREB-2, CREB2, TAXREB67, TXREB | activating transcription factor 4 |
C00002656
|
572 | BAD, BBC2, BCL2L8 | BCL2-associated agonist of cell death |
C00002656
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00002656
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00002656
|
664 | BNIP3, NIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
C00002656
|
79866 | BORA, C13orf34 | bora, aurora kinase A activator |
C00002656
|
7832 | BTG2, PC3, TIS21 | BTG family, member 2 |
C00002656
|
55194 | EVA1B, C1orf78, FAM176B, RP11-268J15.2 | eva-1 homolog B (C. elegans) |
C00031480
|
839 | CASP6, MCH2 | caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) |
C00002656
|
30001 | ERO1L, ERO1-alpha, ERO1A, ERO1LA | ERO1-like (S. cerevisiae) |
C00031480
|
51386 | EIF3L, EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025, MSTP005 | eukaryotic translation initiation factor 3, subunit L |
C00031480
|
8661 | EIF3A, EIF3, EIF3S10, P167, TIF32, eIF3-p170, eIF3-theta, p180, p185 | eukaryotic translation initiation factor 3, subunit A |
C00031480
|
1593 | CYP27A1, CP27, CTX, CYP27 | cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) |
C00031480
|
9134 | CCNE2, CYCE2 | cyclin E2 |
C00002656
|
899 | CCNF, FBX1, FBXO1 | cyclin F |
C00002656
|
942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00002656
|
157313 | CDCA2, Repo-Man | cell division cycle associated 2 |
C00002656
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002656
|
1058 | CENPA, CENP-A, CenH3 | centromere protein A |
C00002656
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00002656
|
1282 | COL4A1, HANAC, ICH, POREN1, arresten | collagen, type IV, alpha 1 |
C00002656
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00002656
|
6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 |
C00002656
|
2017 | CTTN, EMS1 | cortactin |
C00031480
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002656
|
24300 |
C00002656
|
||
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00002656
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00002656
|
1577 | CYP3A5, CP35, CYPIIIA5, P450PCN3, PCN3 | cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1) |
C00002656
|
3491 | CYR61, CCN1, GIG1, IGFBP10 | cysteine-rich, angiogenic inducer, 61 |
C00002656
|
1611 | DAP | death-associated protein |
C00002656
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00002656
|
54541 | DDIT4, Dig2, REDD-1, REDD1 | DNA-damage-inducible transcript 4 |
C00002656
|
22943 | DKK1, DKK-1, SK | dickkopf WNT signaling pathway inhibitor 1 |
C00002656
|
3301 | DNAJA1, DJ-2, DjA1, HDJ2, HSDJ, HSJ2, HSPF4, NEDD7, hDJ-2 | DnaJ (Hsp40) homolog, subfamily A, member 1 |
C00002656
|
1786 | DNMT1, ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT | DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) |
C00002656
|
1788 | DNMT3A, DNMT3A2, M.HsaIIIA | DNA (cytosine-5-)-methyltransferase 3 alpha (EC:2.1.1.37) |
C00002656
|
1789 | DNMT3B, ICF, ICF1, M.HsaIIIB | DNA (cytosine-5-)-methyltransferase 3 beta (EC:2.1.1.37) |
C00002656
|
1999 | ELF3, EPR-1, ERT, ESE-1, ESX | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
C00002656
|
8772 | FADD, MORT1 | Fas (TNFRSF6)-associated via death domain |
C00002656
|
81610 | FAM83D, C20orf129, CHICA, dJ616B8.3 | family with sequence similarity 83, member D |
C00002656
|
26271 | FBXO5, EMI1, FBX5, Fbxo31 | F-box protein 5 |
C00002656
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00002656
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00002656
|
2495 | FTH1, FHC, FTH, FTHL6, PIG15, PLIF | ferritin, heavy polypeptide 1 (EC:1.16.3.1) |
C00002656
|
1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00002656
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00002656
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00031480
|
2937 | GSS, GSHS | glutathione synthetase (EC:6.3.2.3) |
C00002656
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00002656
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00002656
|
3009 | HIST1H1B, H1, H1.5, H1B, H1F5, H1s-3 | histone cluster 1, H1b |
C00002656
|
3007 | HIST1H1D, H1.3, H1D, H1F3, H1s-2 | histone cluster 1, H1d |
C00002656
|
3008 | HIST1H1E, H1.4, H1E, H1F4, H1s-4, dJ221C16.5 | histone cluster 1, H1e |
C00002656
|
85235 | HIST1H2AH, H2A/S, H2AFALii, H2AH, dJ86C11.1 | histone cluster 1, H2ah |
C00002656
|
8329 | HIST1H2AI, H2A/c, H2AFC | histone cluster 1, H2ai |
C00002656
|
8331 | HIST1H2AJ, H2A/E, H2AFE, dJ160A22.4 | histone cluster 1, H2aj |
C00002656
|
8358 | HIST1H3B, H3/l, H3FL | histone cluster 1, H3b |
C00002656
|
8352 | HIST1H3C, H3.1, H3/c, H3FC | histone cluster 1, H3c |
C00002656
|
8359 | HIST1H4A, H4FA | histone cluster 1, H4a |
C00002656
|
8366 | HIST1H4B, H4/I, H4FI | histone cluster 1, H4b |
C00002656
|
8364 | HIST1H4C, H4/g, H4FG, dJ221C16.1 | histone cluster 1, H4c |
C00002656
|
8367 | HIST1H4E, H4/j, H4FJ | histone cluster 1, H4e |
C00002656
|
8361 | HIST1H4F, H4, H4/c, H4FC | histone cluster 1, H4f |
C00002656
|
8365 | HIST1H4H, H4/h, H4FH | histone cluster 1, H4h |
C00002656
|
8362 | HIST1H4K, H4/d, H4F2iii, H4FD, dJ160A22.1 | histone cluster 1, H4k |
C00002656
|
317772 | HIST2H2AB, H2AB | histone cluster 2, H2ab |
C00002656
|
8338 | HIST2H2AC, H2A, H2A-GL101, H2A/q, H2AFQ | histone cluster 2, H2ac |
C00002656
|
8370 | HIST2H4A, FO108, H4, H4/n, H4F2, H4FN, HIST2H4 | histone cluster 2, H4a |
C00002656
|
55355 | HJURP, FAKTS, URLC9, hFLEG1 | Holliday junction recognition protein |
C00002656
|
3148 | HMGB2, HMG2 | high mobility group box 2 |
C00002656
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00002656
|
3306 | HSPA2, HSP70-2, HSP70-3 | heat shock 70kDa protein 2 |
C00002656
|
219844 | HYLS1, HLS | hydrolethalus syndrome 1 |
C00002656
|
3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 |
C00002656
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00002656
|
3689 | ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
C00002656
|
182 | JAG1, AGS, AHD, AWS, CD339, HJ1, JAGL1 | jagged 1 |
C00002656
|
81930 | KIF18A, MS-KIF18A | kinesin family member 18A |
C00002656
|
4254 | KITLG, FPH2, KL-1, Kitl, MGF, SCF, SF, SHEP7 | KIT ligand |
C00002656
|
3910 | LAMA4, CMD1JJ, LAMA3, LAMA4*-1 | laminin, alpha 4 |
C00002656
|
11061 | LECT1, BRICD3, CHM-I, CHM1, MYETS1 | leukocyte cell derived chemotaxin 1 |
C00002656
|
4000 | LMNA, CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL, FPLD, FPLD2, HGPS, IDC, LDP1, LFP, LGMD1B, LMN1, LMNC, LMNL1, PRO1 | lamin A/C |
C00002656
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002656
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002656
|
8932 | MBD2, DMTase, NY-CO-41 | methyl-CpG binding domain protein 2 |
C00002656
|
4257 | MGST1, GST12, MGST, MGST-I | microsomal glutathione S-transferase 1 (EC:2.5.1.18) |
C00002656
|
4323 | MMP14, MMP-14, MMP-X1, MT-MMP, MT-MMP_1, MT1-MMP, MT1MMP, MTMMP1, WNCHRS | matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) |
C00002656
|
4324 | MMP15, MT2-MMP, MTMMP2, SMCP-2 | matrix metallopeptidase 15 (membrane-inserted) (EC:3.4.24.-) |
C00002656
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002656
|
4314 | MMP3, CHDS6, MMP-3, SL-1, STMY, STMY1, STR1 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) |
C00002656
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002656
|
4352 | MPL, C-MPL, CD110, MPLV, THCYT2, TPOR | myeloproliferative leukemia virus oncogene |
C00002656
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00002656
|
571 | BACH1, BACH-1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
C00031480
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00002656
|
10550 | ARL6IP5, DERP11, GTRAP3-18, JWA, PRAF3, addicsin, hp22, jmx | ADP-ribosylation-like factor 6 interacting protein 5 |
C00031480
|
5036 | PA2G4, EBP1, HG4-1, p38-2G4 | proliferation-associated 2G4, 38kDa |
C00002656
|
9870 | AREL1, KIAA0317 | apoptosis resistant E3 ubiquitin protein ligase 1 |
C00031480
|
25796 | PGLS, 6PGL | 6-phosphogluconolactonase (EC:3.1.1.31) |
C00002656
|
5429 | POLH, RAD30, RAD30A, XP-V, XPV | polymerase (DNA directed), eta (EC:2.7.7.7) |
C00002656
|
8493 | PPM1D, PP2C-DELTA, WIP1 | protein phosphatase, Mg2+/Mn2+ dependent, 1D (EC:3.1.3.16) |
C00002656
|
5052 | PRDX1, MSP23, NKEF-A, NKEFA, PAG, PAGA, PAGB, PRX1, PRXI, TDPX2 | peroxiredoxin 1 (EC:1.11.1.15) |
C00002656
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00002656
|
84722 | PSRC1, DDA3, FP3214 | proline/serine-rich coiled-coil 1 |
C00002656
|
9401 | RECQL4, RECQ4 | RecQ protein-like 4 (EC:3.6.4.12) |
C00002656
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002656
|
860 | RUNX2, AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD, OSF-2, OSF2, PEA2aA, PEBP2aA | runt-related transcription factor 2 |
C00002656
|
27244 | SESN1, PA26, SEST1 | sestrin 1 |
C00002656
|
83667 | SESN2, HI95, SES2, SEST2 | sestrin 2 |
C00002656
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00002656
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00002656
|
6688 | SPI1, OF, PU.1, SFPI1, SPI-1, SPI-A | spleen focus forming virus (SFFV) proviral integration oncogene |
C00002656
|
3115 | HLA-DPB1, DPB1, HLA-DP, HLA-DP1B, HLA-DPB | major histocompatibility complex, class II, DP beta 1 |
C00031480
|
7077 | TIMP2, CSC-21K, DDC8 | TIMP metallopeptidase inhibitor 2 |
C00002656
|
25976 | TIPARP, ARTD14, PARP7, pART14 | TCDD-inducible poly(ADP-ribose) polymerase (EC:2.4.2.30) |
C00002656
|
8795 | TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9 | tumor necrosis factor receptor superfamily, member 10b |
C00002656
|
8793 | TNFRSF10D, CD264, DCR2, TRAIL-R4, TRAILR4, TRUNDD | tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain |
C00002656
|
8718 | TNFRSF25, APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR | tumor necrosis factor receptor superfamily, member 25 |
C00002656
|
3604 | TNFRSF9, 4-1BB, CD137, CDw137, ILA | tumor necrosis factor receptor superfamily, member 9 |
C00002656
|
8742 | TNFSF12, APO3L, DR3LG, TWEAK | tumor necrosis factor (ligand) superfamily, member 12 |
C00002656
|
158 | ADSL, AMPS, ASASE, ASL | adenylosuccinate lyase (EC:4.3.2.2) |
C00031480
|
94241 | TP53INP1, SIP, TP53DINP1, TP53INP1A, TP53INP1B, Teap, p53DINP1 | tumor protein p53 inducible nuclear protein 1 |
C00002656
|
8717 | TRADD, Hs.89862 | TNFRSF1A-associated via death domain |
C00002656
|
9618 | TRAF4, CART1, MLN62, RNF83 | TNF receptor-associated factor 4 |
C00002656
|
286827 | TRIM59, MRF1, RNF104, TRIM57, TSBF1 | tripartite motif containing 59 |
C00002656
|
8989 | TRPA1, ANKTM1, FEPS | transient receptor potential cation channel, subfamily A, member 1 |
C00002656
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00002656
|
7474 | WNT5A, hWNT5A | wingless-type MMTV integration site family, member 5A |
C00002656
|
7486 | WRN, RECQ3, RECQL2, RECQL3 | Werner syndrome, RecQ helicase-like (EC:3.6.4.12) |
C00002656
|
212 | ALAS2, ALAS-E, ALASE, ANH1, ASB, XLDPP, XLEPP, XLSA | aminolevulinate, delta-, synthase 2 (EC:2.3.1.37) |
C00002644
|
47 | ACLY, ACL, ATPCL, CLATP | ATP citrate lyase (EC:2.3.3.8) |
C00031480
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00002644
|
6799 | SULT1A2, HAST4, P-PST, ST1A2, STP2, TSPST2 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1) |
C00002644
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00002644
|
6819 | SULT1C2, ST1C1, ST1C2, SULT1C1, humSULTC2 | sulfotransferase family, cytosolic, 1C, member 2 (EC:2.8.2.-) |
C00002644
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00002665
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002665
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002665
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00002665
|
351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00002670
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00002670
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613985 | Beta-thalassemia |
P68871
|
#603902 | Beta-thalassemia, dominant inclusion body type |
P68871
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#218800 | Crigler-najjar syndrome, type i |
P22309
|
#606785 | Crigler-najjar syndrome, type ii |
P22309
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#140700 | Heinz body anemias |
P68871
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#603903 | Sickle cell anemia |
P68871
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601367 | Stroke, ischemic |
P16109
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P68871 (marker) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00025 | Penile cancer |
P08253
(related)
P14780 (related) P35354 (related) |
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00228 | Thalassemia |
P68871
(related)
|
H00229 | Sickle cell anemia (SCA) |
P68871
(related)
|
H00020 | Colorectal cancer |
P68871
(marker)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D048629 | Micronuclei, Chromosome-Defective |
C00031480
C00002656 C00002644 C00002670 |
D011041 | Poisoning |
C00031480
C00002656 C00002644 |
D009784 | Occupational Diseases |
C00002656
C00002644 |
D013959 | Thyroid Diseases |
C00002671
C00002665 |
D002869 | Chromosome Aberrations |
C00002656
C00002644 |
D056486 | Drug-Induced Liver Injury |
C00002656
C00002670 |
D007674 | Kidney Diseases |
C00002656
|
D004487 | Edema |
C00002656
|
D019457 | Chromosome Breakage |
C00002656
|
D007680 | Kidney Neoplasms |
C00002656
|
D008548 | Melanosis |
C00002656
|
D001855 | Bone Marrow Diseases |
C00002656
|
D011123 | Polyploidy |
C00002656
|
D012140 | Respiratory Tract Diseases |
C00002656
|
D012772 | Shock, Septic |
C00002656
|
D012640 | Seizures |
C00002644
|
D011832 | Radiation Injuries |
C00002665
|